Valuation: Haemonetics Corporation

Market Cap 5.6B 5.09B 4.7B 4.24B 8.01B 526B 8.29B 56.51B 22.39B 282B 21.01B 20.56B 894B P/E 2027 *
31.2x
P/E 2028 * 23.5x
Enterprise Value 6.57B 5.97B 5.51B 4.98B 9.4B 617B 9.73B 66.3B 26.27B 331B 24.64B 24.12B 1,048B EV / Sales 2027 *
4.55x
EV / Sales 2028 * 3.91x
Free-Float
98.72%
Yield 2027 *
1.63%
Yield 2028 * -

Last Transcript: Haemonetics Corporation

1 day-1.30%
1 week+2.65%
Current month+1.41%
1 month+2.59%
3 months+34.42%
6 months+111.84%
Current year+51.39%
1 week 116.68
Extreme 116.68
126.08
1 month 115.49
Extreme 115.4924
132
Current year 51
Extreme 51
132
1 year 51
Extreme 51
132
3 years 47.32
Extreme 47.315
132
5 years 43.5
Extreme 43.5
132
10 years 36.44
Extreme 36.44
142.11
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2016
Director of Finance/CFO 55 10/04/2022
Chief Operating Officer 56 31/03/2025
Director TitleAgeSince
Director/Board Member 73 31/12/2005
Director/Board Member 62 15/05/2016
Director/Board Member 71 17/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Tax

Executive/Senior Manager

-146 0.0003%
24/07/26 Free

Director

2,538 0.0056%
24/07/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%+2.65%+63.27%+36.00% 5.6B
-0.99%-2.77%-17.37%+7.17% 188B
+0.02%+0.09%+6.86%+37.39% 126B
+0.35%-4.61%-13.72%+6.58% 118B
+1.18%-4.80%-42.14%+3.55% 92.48B
-0.58%+3.23%-2.21%+81.27% 68.51B
-0.72%+0.57%+13.35%-7.91% 59.39B
-0.51%-0.85%+4.73%+50.15% 55.48B
-2.26%+4.42%-3.31%+45.02% 49.62B
+1.27%+1.50%+1.21%-0.19% 35.17B
Average -0.31%+1.30%+1.07%+25.90% 80B
Weighted average by Cap. -0.25%+0.05%-8.50%+21.89%

Financials

2027 *2028 *
Net sales 1.44B 1.31B 1.21B 1.09B 2.06B 135B 2.14B 14.57B 5.77B 72.71B 5.41B 5.3B 230B 1.6B 1.45B 1.34B 1.21B 2.29B 150B 2.37B 16.14B 6.4B 80.58B 6B 5.87B 255B
Net income 181M 165M 152M 137M 259M 17B 268M 1.83B 724M 9.13B 680M 665M 28.9B 243M 221M 204M 185M 348M 22.86B 361M 2.46B 974M 12.27B 914M 894M 38.86B
Net Debt 969M 881M 814M 735M 1.39B 91.01B 1.44B 9.78B 3.88B 48.84B 3.64B 3.56B 155B 650M 590M 545M 492M 929M 60.99B 962M 6.56B 2.6B 32.73B 2.44B 2.39B 104B
Projected Income Statement - Annual - Haemonetics Corporation
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
16/11/26 US$121.34 -1.30% 365,904
13/11/26 US$122.94 +0.19% 439,696
12/11/26 US$122.71 +1.80% 597,593
11/11/26 US$120.54 -1.49% 390,243
10/11/26 US$122.36 +3.51% 797,947
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Haemonetics Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
122.94USD
Average target price
147.18USD
Spread / Average Target
+19.72%